Theraclion News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

01.12.15	Theraclion Aligns Its Investor Structure and Financial Leadership with Its Long-Term Commercial Ambitions (Businesswire)
30.11.15	Theraclion: First patients treated with new BEAMOTION technology in routine clinical practice (Businesswire)
18.11.15	Theraclion’s New BEAMOTION Procedure Obtains CE Mark (Businesswire)
09.11.15	Presidential Visit to South Korea Acts as Door Opener for Theraclion’s Business in Asia (Businesswire)
04.11.15	Theraclion: Echopulse® to be launched in key German endocrine surgery reference center (Businesswire)
03.11.15	Theraclion: First German patients with thyroid nodules treated with Echopulse® in clinical routine (Businesswire)
15.10.15	THERACLION: Clinical study results demonstrate significant acceleration of Echopulse® treatment due to new BEAMOTION technology (Businesswire)
13.10.15	Theraclion to Host Key Opinion Leader Meeting and Webcast in New York on October 16, 2015 (Businesswire)
06.10.15	Theraclion announces 2015 interim results and provides update on recent corporate activities (Businesswire)
03.09.15	Theraclion’s 2014 Registration Document (Businesswire)
31.08.15	Theraclion Announces First European Commercial Agreements of Echopulse® for the Treatment of Thyroid Nodules (Businesswire)
09.07.15	Theraclion Receives an Additional Financing of €1.1 Million from Bpifrance’s "Industrial Strategic Innovation" Program (Businesswire)
02.07.15	First Echopulse Reference Site in Asia: The University of Hong Kong Awards Tender to Theraclion (Businesswire)
29.06.15	Theraclion’s Managers and Employees Invest in Equity Capital (Businesswire)
17.06.15	Theraclion Raises €4 Million in a Private Placement from Leading European and US Institutional Investors (Businesswire)
11.06.15	Theraclion Announces First Sale in Egypt and over 100 Leads from German and Italian Congresses (Businesswire)
03.06.15	The FDA Accepts to Review Theraclion’s Submission for Approval of an Echopulse Pivotal Trial in the US (Businesswire)
27.04.15	Theraclion: More Than One Million German Patients Now Covered For Echotherapy Treatment (Businesswire)
15.04.15	Theraclion Hires Business Development Director for Asia (Businesswire)
19.03.15	Theraclion Announces Its 2014 Full-Year Results in Line with Expectations (Businesswire)
18.03.15	Theraclion Signs an Equity Line Financing with Kepler Cheuvreux (Businesswire)
18.03.15	Theraclion Announces an Agreement with a German Insurance Company to Cover Breast Fibroadenoma Treatment with Echopulse® for up to Half a Million Germans (Businesswire)
16.03.15	Theraclion Presents Positive Results in Two Studies Published in Radiology and in the Journal of Therapeutic Ultrasound (Businesswire)
12.03.15	Theraclion Continues Its International Expansion with Asia Branch Opening and New Hires in Europe (Businesswire)
12.02.15	Theraclion: First International, Multicentric Study to Present Long-Term Results of Echotherapy in Breast Fibroadenoma (Businesswire)
29.01.15	Theraclion Reports 2014 Revenues of 800 K€ (Businesswire)
13.01.15	New Echopulse® Sales Agreement and First International Publication on a Clinical Study on Breast Fibroadenomas Confirm Theraclion’s Strategy (Businesswire)
07.01.15	Theraclion: 2015 Financial Agenda (Businesswire)
15.12.14	THERACLION : First Echopulse® Commercial Agreement with a Private Imaging Center Expands Treatment in France (Businesswire)
24.11.14	Theraclion Appoints Two Leaders for Business Development in Germany and Asia (Businesswire)
15.10.14	THERACLION Presents Positive Results from a Study Published in the "International Journal of Hyperthermia" (Businesswire)
13.10.14	THERACLION Joins the 4th International Symposium on Focused Ultrasound (Businesswire)
02.10.14	THERACLION presents positive results from a study published in the "Journal of Therapeutic Ultrasound" (Businesswire)
02.10.14	THERACLION: 2014 Interim Results (Businesswire)
11.09.14	Theraclion Announces the First Reimbursement of Its Innovative Echotherapy Solution Echopulse® with Continentale BKK in Germany (Businesswire)
02.09.14	Theraclion Strengthens Its Management Team by Appointing David Caumartin as Theraclion's CEO, and Anja Kleber as Vice-President Marketing/Market Access (Businesswire)
27.08.14	Theraclion Signs an Agreement with Alteris to Distribute Its Innovative Echotherapy Solution Echopulse® in Poland (Businesswire)
20.05.14	Echotherapy specialist Theraclion performed its first two non-invasive treatments of benign breast tumors in the U.S. (Businesswire)
25.04.14	Theraclion Lists on Alternext in Paris (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	97.20	1.68 %	K V
Roche Hldg G	289.40	1.19 %	K V
Swiss Life Hldg	747.60	0.84 %	K V
Alcon	83.48	0.82 %	K V
Sonova Hldg	307.60	0.79 %	K V
Geberit	503.20	0.00 %	K V
Nestle	77.22	-0.31 %	K V
Sika	227.10	-0.48 %	K V
ABB	49.03	-0.65 %	K V
UBS Group	29.33	-0.74 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Theraclion

Aktien Top/Flop

Meistgelesene Nachrichten